Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.
about
Estrogen, male dominance and esophageal adenocarcinoma: is there a link?Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic reviewEarly discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancerAdherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.A feasibility study to evaluate breast cancer patients' knowledge of their diagnosis and treatment.Adherence to long-term adjuvant hormonal therapy for breast cancer.Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I-III breast cancer?Switching between endocrine therapies for primary breast cancer: Frequency and timing in Australian clinical practice.Persistence to 5-year hormonal breast cancer therapy: a French national population-based study.Artichoke polyphenols induce apoptosis and decrease the invasive potential of the human breast cancer cell line MDA-MB231.Socio-demographic and geographic variations in the utilization of hormone therapy in older women with breast cancer after Medicare Part-D coverage.Comparative adherence to oral hormonal agents in older women with breast cancer.A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians.Comparison of Changes in the Lipid Profiles of Eastern Chinese Postmenopausal Women With Early-Stage Breast Cancer Treated With Different Aromatase Inhibitors: A Retrospective Study.Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement.
P2860
Q27023016-8A73818F-CDA0-42A6-8CCB-8D6A99E5DE09Q28082674-C0378D62-0588-47FB-86C7-6290E90C52EFQ33756969-FD6E6E62-21DC-40F2-9871-F018FE65C519Q34445764-7394A433-5981-4988-8648-3D5BCF8F586EQ35075218-16E154CD-C874-4D95-A269-DF592D325617Q36406107-11898753-AC45-4D40-AE4D-01DF3FD9D1D7Q36713559-2F8AB9BB-7816-43C3-A2E9-60835BF23956Q37643271-8A2476DC-FCE9-4FD4-ABE5-8BCE3A611183Q37958054-3677C11B-79EE-4A07-A3D9-1415163AADFDQ38128209-6B588B00-65F6-442E-B803-83A061611CDDQ38756269-AF0F030E-A12C-40AD-B373-4E057CBC6A67Q39292860-198D1A30-736A-4209-AA4D-AC867D74AD27Q39419032-0EC6F985-8715-48A1-8518-1DD7DB33AE78Q39428497-7973E31B-65E9-489B-83C9-B3CF49D94158Q41120416-3E202DDE-FD5E-45F4-8C99-C1606EE2B27FQ41674328-A28B0D0B-D96C-4561-9A0B-28E1F189ED02Q45901122-71010400-E9E4-4742-92FC-A538906E087EQ47233921-BC8D4983-D407-464B-B2CE-201070EED7B6Q52652540-A8A4ED10-0F6B-47E3-B3E2-C8B98A8F0518Q55445320-FE09F30C-AF4E-4658-BBF8-7BFBF1993391
P2860
Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of tamoxifen and aromatase ...... t of women with breast cancer.
@ast
Use of tamoxifen and aromatase ...... t of women with breast cancer.
@en
type
label
Use of tamoxifen and aromatase ...... t of women with breast cancer.
@ast
Use of tamoxifen and aromatase ...... t of women with breast cancer.
@en
prefLabel
Use of tamoxifen and aromatase ...... t of women with breast cancer.
@ast
Use of tamoxifen and aromatase ...... t of women with breast cancer.
@en
P2093
P2860
P356
P1476
Use of tamoxifen and aromatase ...... t of women with breast cancer.
@en
P2093
S Dell'Aniello
P2860
P2888
P304
P356
10.1038/BJC.2011.140
P407
P577
2011-04-26T00:00:00Z